Literature DB >> 26525701

Prevalence of uterine myomas in women in Germany: data of an epidemiological study.

Hans-Joachim Ahrendt1, Heike Tylkoski2, Thomas Rabe3, André Szczes4, Cornelia Friedrich5, Friedrich-Wilhelm Roehl6, Ann Kitay6, Thomas Roemer7, Dolores Foth8.   

Abstract

PURPOSE: Currently, no reliable data are available concerning the prevalence of uterine myomas in Germany. In this prospective study, we examined the prevalence of myomas in women older than 30 years by means of vaginal ultrasound.
METHODS: 2296 women, who consented to the procedure, were examined by means of vaginal ultrasound for the presence of myomas in seven gynaecological outpatient departments in Germany. PREVALENCE: myomas were detected in 41.6 % of all women. Age dependence: With increasing age, the prevalence of uterine myomas rose from 21.3 % (30-35 years) to 62.8 % (46-50 years). Later, the number of myomas decreased again from 56.1 % (51-55 years) to 29.4 % in women older than 55 years. Menarche/BMI: no correlation could be found between the age at first menstrual period or the body mass index and the occurrence of myomas. Parity: since the group of nulliparous women and the group of women with more than four deliveries stand out by increased occurrence of myomas, a non-linear correlation seems to exist, necessitating more in-depth discussion with regard to age dependency.
CONCLUSIONS: The results of this study suggest that more than 40 % of women over 30 years of age suffered from myomas and more than 50 % of all women in Germany may develop uterine myomas at some time in their life.

Entities:  

Keywords:  Prevalence of myomas; Uterine leiomyomas; Uterine myomas; Vaginal ultrasound

Mesh:

Year:  2015        PMID: 26525701     DOI: 10.1007/s00404-015-3930-8

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  4 in total

1.  Burden of uterine fibroids in Italy: epidemiology, treatment outcomes, and consumption of health care resources in more than 5,000 women.

Authors:  Marco Chiumente; Mauro De Rosa; Andrea Messori; Enrica Maria Proli
Journal:  Clinicoecon Outcomes Res       Date:  2017-08-29

Review 2.  Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate.

Authors:  Thomas Rabe; Nicole Saenger; Andreas D Ebert; Thomas Roemer; Hans-Rudolf Tinneberg; Rudy Leon De Wilde; Markus Wallwiener
Journal:  Biomed Res Int       Date:  2018-06-24       Impact factor: 3.411

3.  Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE): Study Protocol and Preliminary Results.

Authors:  Ladina Christoffel; Thomas Römer; Sven Schiermeier
Journal:  Med Devices (Auckl)       Date:  2021-03-03

4.  A transcriptome-wide association study of uterine fibroids to identify potential genetic markers and toxic chemicals.

Authors:  Gayeon Kim; Gyuyeon Jang; Jaeseung Song; Daeun Kim; Sora Lee; Jong Wha J Joo; Wonhee Jang
Journal:  PLoS One       Date:  2022-09-29       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.